Key references: Glycaemic targets and monitoring for women with hyperglycaemia in pregnancy (including gestational diabetes)

  • American Diabetes Association. 13. Management of diabetes in pregnancy: Standards of medical care in diabetes-2018. Diabetes Care 2018;41(Suppl 1):S137–S43. https://www.ncbi.nlm.nih.gov/pubmed/29222384
  • Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42(8):1593-603. https://www.ncbi.nlm.nih.gov/pubmed/31177185
  • Diabetes Canada Clinical Practice Guidelines Expert Committee, Feig DS, Berger H, Donovan L, Godbout A, Kader T, et al. Diabetes and pregnancy. Can J Diabetes 2018;42 Suppl 1:S255–S82. https://www.ncbi.nlm.nih.gov/pubmed/29650105
  • National Institute for Health and Care Excellence (NICE). Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. London: NICE; 2015. https://www.nice.org.uk/guidance/ng3
  • Piper LK, Stewart Z, Murphy HR. Gestational diabetes. Obstet Gynaecol Reprod Med 2017;27(6):171–6. https://doi.org/10.1016/j.ogrm.2017.03.004
  • Scott EM, Bilous RW, Kautzky-Willer A. Accuracy, user acceptability, and safety evaluation for the freestyle libre flash glucose monitoring system when used by pregnant women with diabetes. Diabetes Technol Ther 2018;20(3):180–8. https://www.ncbi.nlm.nih.gov/pubmed/29470094